广康生化(300804)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300804 广康生化

已收盘 07-30 15:00:00

{"stockData":{"symbol":"300804","market":"SZ","secType":"STK","nameCN":"广康生化","latestPrice":42.65,"timestamp":1753858986000,"preClose":43.17,"halted":0,"volume":3520250,"delay":0,"changeRate":-0.012,"floatShares":27500000,"shares":74000000,"eps":0.4611,"marketStatus":"已收盘","change":-0.52,"latestTime":"07-30 15:00:00","open":42.75,"high":43.74,"low":42.37,"amount":152000000,"amplitude":0.0317,"askPrice":42.66,"askSize":17,"bidPrice":42.65,"bidSize":32,"shortable":0,"etf":0,"ttmEps":0.4611,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753925400000},"marketStatusCode":5,"adr":0,"adjPreClose":43.17,"symbolType":"stock","openAndCloseTimeList":[[1753839000000,1753846200000],[1753851600000,1753858800000]],"highLimit":47.49,"lowLimit":38.85,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":74000000,"isCdr":false,"pbRate":2.38,"roa":"--","peRate":92.496205,"roe":"1.29%","epsLYR":0.47,"committee":0.685246,"marketValue":3156000000,"turnoverRate":0.128,"status":1,"floatMarketCap":1173000000},"requestUrl":"/m/hq/s/300804","defaultTab":"news","newsList":[{"id":"2555000487","title":"广康生化：公司未取得卫生用农药相关登记资质","url":"https://stock-news.laohu8.com/highlight/detail?id=2555000487","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555000487?lang=zh_cn&edition=full","pubTime":"2025-07-29 09:09","pubTimestamp":1753751362,"startTime":"0","endTime":"0","summary":"证券之星消息，广康生化07月28日在投资者关系平台上答复投资者关心的问题。我司的主营业务是农药原药、中间体、制剂的研发、生产和销售。我司生产的部分农药杀虫剂对灭蚊有一定的防治效果，但我司产品若要用于卫生杀虫领域，则需严格遵守相关法律法规，取得相关登记审批和资质认证。目前，公司未取得卫生用农药相关登记资质。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072900008041.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300804"],"gpt_icon":0},{"id":"2554774795","title":"广康生化选举林阳涵为职工代表董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2554774795","media":"财中社","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554774795?lang=zh_cn&edition=full","pubTime":"2025-07-28 20:44","pubTimestamp":1753706640,"startTime":"0","endTime":"0","summary":"7月28日，广康生化（300804）发布公告，经与会职工讨论和表决，一致同意选举林阳涵为公司第四届董事会职工代表董事。2025年一季度，广康生化实现收入1.87亿元，归母净利润1711万元。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/zqgd/2025-07-28/doc-infhztuq1499807.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300804","BK0229"],"gpt_icon":0},{"id":"2552468655","title":"广康生化：公司制剂产品主要为杀菌剂、除草剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2552468655","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552468655?lang=zh_cn&edition=full","pubTime":"2025-07-18 15:54","pubTimestamp":1752825250,"startTime":"0","endTime":"0","summary":"证券之星消息，广康生化(300804)07月18日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，请问公司自产的农药原药会用于自身制剂产品生产吗？用于生产农药制剂产品的原药都有哪些？用于生产农药制剂产品的原药占比大吗？广康生化回复：您好！公司销售的制剂产品，一部分为用公司原药生产的制剂，另一部分为外购或委托加工制剂，目前制剂产品主要为杀菌剂、除草剂。2024年，公司制剂产品实现销售额约7000万元，约占营业收入的9.68%。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071800022336.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804","BK0229"],"gpt_icon":0},{"id":"2552575101","title":"广康生化：年产5,500吨特种化学品建设项目产品规划","url":"https://stock-news.laohu8.com/highlight/detail?id=2552575101","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552575101?lang=zh_cn&edition=full","pubTime":"2025-07-17 15:54","pubTimestamp":1752738845,"startTime":"0","endTime":"0","summary":"证券之星消息，广康生化07月17日在投资者关系平台上答复投资者关心的问题。投资者提问：贵司在建宜昌的两个甲级车间3500吨产能，是准备做哪块的产能？公司于2025年4月对宜昌“年产3,500吨特种化学品建设项目”进行了调整，调整后，该项目名称变更为“年产5,500吨特种化学品建设项目”，项目规划生产的产品名称为叶菌唑、灭菌唑、种菌唑、苯酰菌胺、甜菜宁、甜菜安、3,5-二甲基苯甲酸。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071700022079.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300804"],"gpt_icon":0},{"id":"2550167083","title":"广康生化：公司K胺项目已取得安评批复环评批复","url":"https://stock-news.laohu8.com/highlight/detail?id=2550167083","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550167083?lang=zh_cn&edition=full","pubTime":"2025-07-11 08:36","pubTimestamp":1752194170,"startTime":"0","endTime":"0","summary":"证券之星消息，广康生化(300804)07月10日在投资者关系平台上答复投资者关心的问题。投资者提问：目前公司有无k胺项目申请计划？是否会根据市场情况申请安全专项皮肤？广康生化回复：您好！公司K胺项目已取得安评批复、环评批复，目前公司未申请K胺项目的安全设计专篇，未来公司将结合整体战略规划以及市场动态，综合评估后决定是否推进相关申请事宜。谢谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071100005682.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804","BK0229"],"gpt_icon":0},{"id":"2550520071","title":"广康生化股价震荡下行 控股股东质押200万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2550520071","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550520071?lang=zh_cn&edition=full","pubTime":"2025-07-09 03:23","pubTimestamp":1752002631,"startTime":"0","endTime":"0","summary":"截至2025年7月8日15时10分，广康生化股价报49.90元，较前一交易日下跌1.40%。当日开盘价为51.12元，最高触及51.99元，最低下探至49.80元，成交量为39537手，成交金额达2亿元。2025年一季度，公司实现营业收入1.87亿元，净利润1711万元。7月8日公司公告显示，控股股东蔡丹群质押200万股股份，占其所持股份的7.75%。截至公告日，蔡丹群及其一致行动人累计质押股份400万股，占其持股总数的8.6%。当日盘中，公司股价曾出现快速反弹，5分钟内涨幅超过2%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/09032351571591.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0229","300804"],"gpt_icon":0},{"id":"2549545459","title":"广康生化（300804）股东蔡丹群质押200万股，占总股本2.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549545459","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549545459?lang=zh_cn&edition=full","pubTime":"2025-07-08 18:22","pubTimestamp":1751970146,"startTime":"0","endTime":"0","summary":"证券之星消息，广康生化7月8日公开信息显示，股东蔡丹群向深圳市高新投融资担保有限公司合计质押200.0万股，占总股本2.7%。质押详情见下表：截止本公告日，股东蔡丹群已累计质押股份400.0万股，占其持股总数的15.49%。广康生化主营业务：农药原药、中间体、制剂的研发、生产和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070800032095.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804","BK0229"],"gpt_icon":0},{"id":"2548604423","title":"广康生化：公司K胺项目目前无开工建设计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2548604423","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548604423?lang=zh_cn&edition=full","pubTime":"2025-07-01 08:51","pubTimestamp":1751331074,"startTime":"0","endTime":"0","summary":"证券之星消息，广康生化06月30日在投资者关系平台上答复投资者关心的问题。给投资者一个明确的信息，不要一天在那没有计划没有计划的。就是想糊弄投资者广康生化回复：您好！公司未申请K胺项目安全设计专篇，根据公司总体整体规划安排，公司K胺项目目前无开工建设计划。公司严格按照信息披露相关法律法规规范运作，在信息披露方面做到应披尽披。感谢您对公司的持续关注！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070100008087.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300804"],"gpt_icon":0},{"id":"2547598230","title":"A股异动丨广康生化跌约4% 瑞宏凯银壹号完成减持3%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2547598230","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547598230?lang=zh_cn&edition=full","pubTime":"2025-06-30 13:49","pubTimestamp":1751262541,"startTime":"0","endTime":"0","summary":"广康生化(300804.SZ)今日早盘一度跌3.93%至51.03元。广康生化公布，截至2025年6月27日，股东瑞宏凯银壹号本次减持计划已实施完毕，合计减持222万股，本次减持占总股本的比例3%。(格隆汇)","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/30134951383850.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300804","399300","159982","BK0229"],"gpt_icon":0},{"id":"2546712280","title":"广康生化(300804.SZ)股东瑞宏凯银壹号完成减持 合计减持3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2546712280","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546712280?lang=zh_cn&edition=full","pubTime":"2025-06-27 18:25","pubTimestamp":1751019959,"startTime":"0","endTime":"0","summary":"智通财经APP讯，广康生化(300804.SZ)公告，公司收到股东瑞宏凯银壹号《关于股份减持计划实施完毕的告知函》。截至2025年6月27日，瑞宏凯银壹号减持计划已实施完毕，合计减持公司股份222万股，占总股本的比例为3%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1310990.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0229","300804"],"gpt_icon":0},{"id":"2546159897","title":"6月27日广康生化现1笔大宗交易 机构净买入7681.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546159897","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546159897?lang=zh_cn&edition=full","pubTime":"2025-06-27 17:10","pubTimestamp":1751015452,"startTime":"0","endTime":"0","summary":"证券之星消息，6月27日广康生化发生大宗交易，交易数据如下：大宗交易成交价格51.9元，相对当日收盘价折价2.3%，成交148万股，成交金额7681.2万元，买方营业部为机构专用，卖方营业部为广发证券股份有限公司深圳福华一路证券营业部。近三个月该股共发生3笔大宗交易，合计成交2.96万手，折价成交3笔。该股近期无解禁股上市。截至2025年6月27日收盘，广康生化报收于53.12元，下跌7.21%，换手率21.91%，成交量6.03万手，成交额3.19亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062700028217.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300804"],"gpt_icon":0},{"id":"2546684957","title":"广康生化：公司未申请K胺项目安全设计专篇","url":"https://stock-news.laohu8.com/highlight/detail?id=2546684957","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546684957?lang=zh_cn&edition=full","pubTime":"2025-06-27 08:43","pubTimestamp":1750984991,"startTime":"0","endTime":"0","summary":"证券之星消息，广康生化(300804)06月26日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好！请问一下贵司K胺项目安全设计专篇的进度如何？申请时间是哪个月份？广康生化回复：回复：您好！公司未申请K胺项目安全设计专篇，根据公司总体整体规划安排，公司K胺项目目前无开工建设计划。在此，我们特别提示您注意二级市场交易风险，理性投资并审慎做出决策。感谢您对公司的持续关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062700007702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804","BK0229"],"gpt_icon":0},{"id":"2546927789","title":"广康生化收盘上涨1.33%，滚动市盈率124.16倍，总市值42.37亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546927789","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546927789?lang=zh_cn&edition=full","pubTime":"2025-06-26 18:11","pubTimestamp":1750932675,"startTime":"0","endTime":"0","summary":"6月26日，广康生化今日收盘57.25元，上涨1.33%，滚动市盈率PE达到124.16倍，总市值42.37亿元。从行业市盈率排名来看，公司所处的农药兽药行业市盈率平均49.14倍，行业中值38.21倍，广康生化排名第44位。截至2025年一季报，共有8家机构持仓广康生化，其中其他6家、券商1家、基金1家，合计持股数901.33万股，持股市值2.17亿元。广东广康生化科技股份有限公司的主营业务是农药原药、中间体、制剂的研发、生产和销售。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/26181151325747.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0229","300804"],"gpt_icon":0},{"id":"2546121743","title":"6月25日广康生化发布公告，股东减持50.01万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2546121743","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546121743?lang=zh_cn&edition=full","pubTime":"2025-06-25 20:01","pubTimestamp":1750852905,"startTime":"0","endTime":"0","summary":"证券之星消息，6月25日广康生化发布公告《广康生化:简式权益变动报告书(瑞宏凯银壹号)》，其股东共青城瑞宏凯银壹号股权投资基金合伙企业(有限合伙)于2025年6月25日合计减持50.01万股，占公司目前总股本的0.6758%，变动期间该股股价下跌8.87%，截止6月25日收盘报56.5元。股东增减持详情见下表：根据广康生化2025年一季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062500034220.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300804"],"gpt_icon":0},{"id":"2545218294","title":"广康生化：K胺项目目前无开工建设计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2545218294","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545218294?lang=zh_cn&edition=full","pubTime":"2025-06-24 08:40","pubTimestamp":1750725628,"startTime":"0","endTime":"0","summary":"证券之星消息，广康生化(300804)06月23日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，贵司近日说“公司目前尚未启动K胺项目的安全设计专篇编制工作”。那么，请问贵司决策层是否已经决定马上投资建设K胺项目？如果是的话，现在该项目在进行初步设计了吗？广康生化回复：您好！根据公司总体整体规划安排，公司K胺项目目前无开工建设计划。在此，我们特别提示您注意二级市场交易风险，理性投资并审慎做出决策。感谢您对公司的持续关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062400006584.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300804"],"gpt_icon":0},{"id":"2545846106","title":"农业种植概念盘中拉升，广康生化涨5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545846106","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545846106?lang=zh_cn&edition=full","pubTime":"2025-06-23 13:29","pubTimestamp":1750656554,"startTime":"0","endTime":"0","summary":"06月23日，农业种植概念盘中拉升，截至13点29分，农业种植概念整体指数上涨1.01%，报1708.190点。从个股上来看，该概念的成分股中，广康生化涨5.78%，远大控股涨幅超过5%。从资金上来看，截止发稿，农业种植概念主力净流入为-2658.60万，其中苏垦农发受到资金热捧，主力净流入2960.03万；拉长时间线来看，该板块近20日主力资金净流入-44.41亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623132914a4b846a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623132914a4b846a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0229","300804","601952","BK0238"],"gpt_icon":0},{"id":"2544159248","title":"广康生化：公司严格按照信息披露相关法律法规规范运作","url":"https://stock-news.laohu8.com/highlight/detail?id=2544159248","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544159248?lang=zh_cn&edition=full","pubTime":"2025-06-19 16:45","pubTimestamp":1750322715,"startTime":"0","endTime":"0","summary":"证券之星消息，广康生化(300804)06月19日在投资者关系平台上答复投资者关心的问题。投资者提问：你好董秘，有个叫鑫多多的原名刘鑫，在各大平台吹公司的K胺在建产能，让他的粉丝跟买公司股票，这算违法违规吗？广康生化回复：您好！公司严格按照信息披露相关法律法规规范运作，对于个别投资者的行为不做具体评判。在此，我们特别提示您，证券投资是一种高风险投资，投资者应根据市场情况、自身风险承受能力等因素，谨慎判断和决策。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061900023616.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300804"],"gpt_icon":0},{"id":"2544930951","title":"广康生化：根据规定截至目前公司尚未收到任何股东发出的关于其持股达到公司总股本5%或以上的权益变动通知","url":"https://stock-news.laohu8.com/highlight/detail?id=2544930951","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544930951?lang=zh_cn&edition=full","pubTime":"2025-06-17 16:36","pubTimestamp":1750149370,"startTime":"0","endTime":"0","summary":"证券之星消息，广康生化06月17日在投资者关系平台上答复投资者关心的问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061700024684.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300804"],"gpt_icon":0},{"id":"2543624478","title":"广康生化收盘上涨9.69%，滚动市盈率137.78倍，总市值47.01亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543624478","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543624478?lang=zh_cn&edition=full","pubTime":"2025-06-16 16:56","pubTimestamp":1750064210,"startTime":"0","endTime":"0","summary":"6月16日，广康生化今日收盘63.53元，上涨9.69%，滚动市盈率PE达到137.78倍，总市值47.01亿元。从行业市盈率排名来看，公司所处的农药兽药行业市盈率平均52.59倍，行业中值39.68倍，广康生化排名第44位。截至2025年一季报，共有8家机构持仓广康生化，其中其他6家、券商1家、基金1家，合计持股数901.33万股，持股市值2.17亿元。广东广康生化科技股份有限公司的主营业务是农药原药、中间体、制剂的研发、生产和销售。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/16165651092167.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0229","300804"],"gpt_icon":0},{"id":"2543641817","title":"广康生化：公司氯虫苯甲酰胺产品环评设计产能为10吨/年目前该产品尚未投产","url":"https://stock-news.laohu8.com/highlight/detail?id=2543641817","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543641817?lang=zh_cn&edition=full","pubTime":"2025-06-16 11:36","pubTimestamp":1750044984,"startTime":"0","endTime":"0","summary":"公司K胺项目于2024年取得环评批复和安全预评价批复，未取得安全设计专篇审批。公司氯虫苯甲酰胺产品环评设计产能为10吨/年，目前该产品尚未投产，后续在完成投产相关流程后，预计该产品对公司整体业绩的贡献较小。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061600009432.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300804"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753881771363,"stockEarnings":[{"period":"1week","weight":-0.0329},{"period":"1month","weight":-0.1873},{"period":"3month","weight":0.7179},{"period":"6month","weight":0.8568},{"period":"1year","weight":1.1256},{"period":"ytd","weight":0.9136}],"compareEarnings":[{"period":"1week","weight":0.0078},{"period":"1month","weight":0.0542},{"period":"3month","weight":0.1008},{"period":"6month","weight":0.1105},{"period":"1year","weight":0.2482},{"period":"ytd","weight":0.077}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广东广康生化科技股份有限公司","boardCode":"AI0026","boardName":"化学原料和化学制品制造业","stockholders":"8501人(较上一季度增加0.04%)","perCapita":"3234股","listingDate":"2023-06-27","address":"广东省清远市英德市农用化工产业链专用基地(英德市沙口镇红丰管理区)","registeredCapital":"7400万元","survey":"　　广东广康生化科技股份有限公司的主营业务是农药原药、中间体、制剂的研发、生产和销售。公司的主要产品是灭菌丹、克菌丹、噻呋酰胺、土菌灵、萎锈灵、联苯肼酯、甲氧虫酰肼、甜菜宁、甜菜安、乙氧呋草黄。公司是中国农药发展与应用协会理事单位、中国石油化工优秀民营企业、中国农药工业协会AA级信用企业。","listedPrice":42.45},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"广康生化(300804)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供广康生化(300804)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"广康生化,300804,广康生化股票,广康生化股票老虎,广康生化股票老虎国际,广康生化行情,广康生化股票行情,广康生化股价,广康生化股市,广康生化股票价格,广康生化股票交易,广康生化股票购买,广康生化股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"广康生化(300804)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供广康生化(300804)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}